The role of imaging in the clinical practice of radiation oncology for pancreatic cancer

被引：0
作者：
Eugene J. Koay
William Hall
Peter C. Park
Beth Erickson
Joseph M. Herman
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[2] Medical College of Wisconsin,Department of Radiation Oncology
[3] MD Anderson Cancer Center,Department of Radiation Physics
来源：
Abdominal Radiology | 2018年 / 43卷
关键词：
Pancreatic cancer; Image guidance; Radiotherapy; Stereotactic body radiation therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Advances in technology have enabled the delivery of high doses of radiation therapy for pancreatic ductal adenocarcinoma (PDAC) with low rates of toxicity. Although the role of radiation for pancreatic cancer continues to evolve, encouraging results with newer techniques indicate that radiation may benefit selected patient populations. Imaging has been central to the modern successes of radiation therapy for PDAC. Here, we review the role of diagnostic imaging, imaging-based planning, and image guidance in radiation oncology practice for PDAC.
引用
收藏
页码：393 / 403
页数：10
相关论文
共 273 条
[1]  
Rahib L(2014)Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res 74 2913-2921
[2]  
Smith BD(2009)DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol 27 1806-1813
[3]  
Aizenberg R(2010)Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study Ann Surg Oncol 17 981-990
[4]  
Rosenzweig AB(2010)Adjuvant chemoradiotherapy for resected pancreas cancer World J Gastrointest Surg 2 373-380
[5]  
Fleshman JM(2012)Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins J Gastrointest Cancer 43 70-76
[6]  
Matrisian LM(2005)Radiochemotherapy in the management of pancreatic cancer–part I: neoadjuvant treatment Semin Radiat Oncol 15 226-234
[7]  
Iacobuzio-Donahue CA(2015)Advances of stereotactic body radiotherapy in pancreatic cancer Chin J Cancer Res 27 349-357
[8]  
Fu B(2014)Management of borderline resectable pancreatic cancer Semin Radiat Oncol 24 105-112
[9]  
Yachida S(2016)Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial JAMA 315 1844-1853
[10]  
Luo M(2011)Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial J Clin Oncol 29 4105-4112
12345678910